Platelet-derived growth factor and wound contraction in the rat

Area of Science:

• Wound healing research
• Pharmacology
• Tissue regeneration

Background:

• Glucocorticoids are known to impair wound healing.
• Platelet-derived growth factor (PDGF) has shown potential in promoting tissue repair.
• Previous preliminary studies suggested PDGF might enhance wound contraction in steroid-impaired rats.

Purpose of the Study:

• To establish a dose-response relationship for acute steroid inhibition of wound contraction in rats.
• To validate the preliminary finding that PDGF enhances wound contraction in steroid-impaired rats.
• To histologically analyze wounds treated with PDGF.

Main Methods:

• Rats were administered daily doses of methylprednisolone to determine steroid inhibition levels.
• Wound contraction was measured to assess healing.
• Rats were treated with methylprednisolone or hydrocortisone and topical recombinant PDGF-BB (rPDGF-BB) to evaluate PDGF's effect.
• Histological examination of wound tissues was performed.

Main Results:

• Significant inhibition of wound contraction was observed with daily methylprednisolone doses of 2.0 mg/wound/day (6.7 mg/kg/day).
• Topical rPDGF-BB administration did not improve the rate or extent of wound contraction in steroid-impaired rats.
• Histological analysis revealed no significant differences in cellularity, granulation tissue, collagen content, or epithelial migration between PDGF-treated and control wounds.

Conclusions:

• The dose-response curve for acute steroid inhibition of wound contraction in rats has been clarified.
• Platelet-derived growth factor (PDGF) does not appear to enhance wound healing in steroid-impaired rats at the tested doses.
• PDGF treatment did not alter the histological characteristics of steroid-impaired wounds.